Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
about
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell LinesRepurposing medicinal compounds for blood cancer treatment.Clinical response in patients with ovarian cancer treated with metronomic chemotherapy.The Biological Activities of Sesterterpenoid-Type Ophiobolins.Bacterial xenophagy and its possible role in cancer: A potential antimicrobial strategy for cancer prevention and treatment.Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels.Clarithromycin as a "repurposing drug" against MALT lymphoma.A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus - clinical significance and possible mechanisms: a case report.The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy.Roxithromycin monotherapy inducing a partial response in a patient with myeloma: a case report.Repurposing drugs in oncology (ReDO)-selective PDE5 inhibitors as anti-cancer agents.A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
P2860
Q30367534-3D378475-13B7-462A-A4E8-2EFBC6EE8D31Q35807959-A017E236-6B99-434A-9E33-B9FE90018D61Q37679904-9E23F848-B86A-4005-8E4A-B1D97D31D03CQ38656001-457161C1-A7CB-42B5-8F2C-6E8F7FDBE7CEQ40420981-226DB1F5-688C-43B0-8DB3-02769E1EC2B1Q42577166-C8E98E48-7D82-481F-A65F-C5F6885301FDQ48298220-9EC53B2A-EA1E-4EEC-B5BB-469CED4A5648Q49900433-68E64EF7-28FE-4190-8C88-BD9E897EC149Q50010969-AA395031-31FF-4EB6-9714-E7CCCCABF9C4Q55188922-CDF484A1-AFE7-47B7-8548-920D715371E0Q55247585-0D866E95-15C1-4A4A-A0A3-E911C4EE992AQ58786182-B3FE4F33-6874-4A00-BF1D-32498EF80562
P2860
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
@en
type
label
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
@en
prefLabel
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
@en
P2093
P2860
P356
P1476
Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent
@en
P2093
Gauthier Bouche
Lydie Meheus
Vidula Sukhatme
Vikas P Sukhatme
P2860
P356
10.3332/ECANCER.2015.513
P577
2015-02-24T00:00:00Z